Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: Influence of pore size on release rate

Materials Science and Engineering C

Volumn 34, Issue 1, 2014, Pages 78-85

  Zhu, Wenquan ^a   Wan, Long ^a   Zhang, Chen ^a   Gao, Yikun ^a   Zheng, Xin ^a   Jiang, Tongying ^a   Wang, Siling ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

3D face centered cubic mesoporous silica; Drug delivery system; Improved dissolution; Poorly water soluble drug; Pore size

Indexed keywords

DIFFERENT PORE SIZES; DRUG DELIVERY SYSTEM; FOURIER TRANSFORMATIONS; IN-VITRO DISSOLUTION; MESOPOROUS SILICA; NON-CRYSTALLINE STATE; POORLY WATER-SOLUBLE DRUGS; REACTION TEMPERATURE;

CRYSTALLINE MATERIALS; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG DELIVERY; FOURIER TRANSFORMS; GAS ADSORPTION; INFRARED SPECTROSCOPY; MESOPOROUS MATERIALS; SCANNING ELECTRON MICROSCOPY; THERMOGRAVIMETRIC ANALYSIS; THREE DIMENSIONAL; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

PORE SIZE;

CELECOXIB; DRUG CARRIER; NITROGEN; PYRAZOLE DERIVATIVE; SILICON DIOXIDE; SULFONAMIDE; WATER;

3D FACE-CENTERED CUBIC MESOPOROUS SILICA; ADSORPTION; ARTICLE; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; IMPROVED DISSOLUTION; INFRARED SPECTROSCOPY; POORLY WATER SOLUBLE DRUG; PORE SIZE; POROSITY; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

3D FACE-CENTERED CUBIC MESOPOROUS SILICA; DRUG DELIVERY SYSTEM; IMPROVED DISSOLUTION; POORLY WATER SOLUBLE DRUG; PORE SIZE;

ADSORPTION; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NITROGEN; POROSITY; PYRAZOLES; SILICON DIOXIDE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SULFONAMIDES; THERMOGRAVIMETRY; WATER; X-RAY DIFFRACTION;

EID: 84889083140     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2013.08.014     Document Type: Article

References (47)

1. F. Chen Chitosan enclosed mesoporous silica nanoparticles as drug nano-carriers: sensitive response to the narrow pH range Microporous Mesoporous Mater. 150 2012 83 89
2. C.X. Lin Periodic mesoporous silica and organosilica with controlled morphologies as carriers for drug release Microporous Mesoporous Mater. 117 2009 213 219
3. T. Heikkila Mesoporous silica material TUD-1 as a drug delivery system Int. J. Pharm. 331 2007 133 138 (Pubitemid 46176505)
4. Y. Zhu PEGylated hollow mesoporous silica nanoparticles as potential drug delivery vehicles Microporous Mesoporous Mater. 141 2011 199 206
5. X. Li Preparation of mesoporous calcium doped silica spheres with narrow size dispersion and their drug loading and degradation behavior Microporous Mesoporous Mater. 102 2007 151 158 (Pubitemid 46603114)
6. M. Vialpando Risk assessment of premature drug release during wet granulation of ordered mesoporous silica loaded with poorly soluble compounds itraconazole, fenofibrate, naproxen, and ibuprofen Eur. J. Pharm. Biopharm. 81 2012 190 198
7. I. Slowing Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers Adv. Drug Deliv. Rev. 60 2008 1278 1288
8. M. Liu A novel liposome-encapsulated hemoglobin/silica nanoparticle as an oxygen carrier Int. J. Pharm. 427 2012 354 357
9. H. Peng A pH-responsive nano-carrier with mesoporous silica nanoparticles cores and poly(acrylic acid) shell-layers: fabrication, characterization and properties for controlled release of salidroside Int. J. Pharm. 446 2013 153 159
10. J. Liu Magnetic silica spheres with large nanopores for nucleic acid adsorption and cellular uptake Biomaterials 33 2012 970 978
11. S. Wang Ordered mesoporous materials for drug delivery Microporous Mesoporous Mater. 117 2009 1 9
12. Y. Zhou 3D net-linked mesoporous silica monolith: new environmental adsorbent and catalyst Catal. Today 166 2011 39 46
13. Y. Hu Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug J. Colloid Interface Sci. 363 2011 410 417
14. W. Na Large pore 3D cubic mesoporous silica HOM-5 for enzyme immobilization Mater. Lett. 62 2008 3707 3709
15. J. Huang Large-pore cubic Ia-3d mesoporous silicas: synthesis, modification and catalytic applications J. Mol. Catal. A Chem. 271 2007 200 208 (Pubitemid 46710498)
16. Y. Hu 3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol Microporous Mesoporous Mater. 147 2012 94 101
17. S.K. Das Effects of surface acidity and pore size of mesoporous alumina on degree of loading and controlled release of ibuprofen Microporous Mesoporous Mater. 118 2009 267 272
18. F. Qu Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica Microporous Mesoporous Mater. 92 2006 1 9 (Pubitemid 43782508)
19. Y.P. Wang Control of pore size in mesoporous silica templated by a multiarm hyperbranched copolyether in water and cosolvent Microporous Mesoporous Mater. 120 2009 447 453
20. M.J.K. Thomas Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles Int. J. Pharm. 387 2010 272 277
21. L. Huang Synthesis of ultra-large-pore FDU-12 silica using ethylbenzene as micelle expander J. Colloid Interf. Sci. 365 2012 137 142
22. S.Y. Kwon Charged molecular effect on the degree of ordering of mesostructured silica thin film templated by mixed ionic micelles Thin Solid Films 516 2008 2843 2847 (Pubitemid 351288763)
23. S. Budi Hartono Improving adsorbent properties of cage-like ordered amine functionalized mesoporous silica with very large pores for bioadsorption Langmuir 25 2009 6413 6424
24. J. Dong Intra-articular delivery of liposomal celecoxib-hyaluronate combination for the treatment of osteoarthritis in rabbit model Int. J. Pharm. 441 2013 285 290
25. B.P. Schachtel Efficacy of low-dose celecoxib in patients with acute pain J. Pain 12 2011 756 763
26. V. Jendrossek Targeting apoptosis pathways by Celecoxib in cancer Cancer Lett. 332 2013 313 324
27. Y.X. Yan The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function Prostaglandins Other Lipid Mediat. 97 2012 29 35
28. N. Debnath Synthesis of surface functionalized silica nanoparticles and their use as entomotoxic nanocides Powder Technol. 221 2012 252 256
29. C. Uboldi Amorphous silica nanoparticles do not induce cytotoxicity, cell transformation or genotoxicity in Balb/3T3 mouse fibroblasts Mutat. Res. Genet. Toxicol. Environ. 745 2012 11 20
30. L. Jia In vitro and in vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizes Int. J. Pharm. 445 2013 12 19
31. L. Jia Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs Int. J. Pharm. 439 2012 81 91
32. S.B. Hartono Improving adsorbent properties of cage-like ordered amine functionalized mesoporous silica with very large pores for bioadsorption Langmuir 25 2009 6413 6424
33. F.J. Zhang Facile aqueous route to synthesize highly ordered mesoporous polymers and carbon frameworks with Ia3hd bicontinuous cubic structure J. Am. Chem. Soc. 127 2005 13508 13509
34. J. Fan Cubic mesoporous silica with large controllable entrance sizes and advanced adsorption properties Angew. Chem. Int. Ed. 115 2003 3254 3258
35. B. Shewale Effect of hydroxylpropyl-β-cyclodextrin on solubility of carvedilol Indian J. Pharm. Sci 70 2008 255
36. T. Loftsson Carvedilol: solubilization and cyclodextrin complexation: a technical note AAPS Pharm. Sci. Tech. 9 2008 425 430
37. V. Ambrogi Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate Eur. J. Pharm. Sci. 32 2007 216
38. S. Kapoor Influence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug release J. Control. Release 140 2009 34 39
39. J. Salonen Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs J. Control. Release 108 2005 362 374 (Pubitemid 41608668)
40. Y. Zhang Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan J. Control. Release 145 2010 257 263
41. Y. Zhang Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: drug loading and release properties Int. J. Pharm. 410 2011 118 124
42. Y. Zhang Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property Eur. J. Pharm. Biopharm. 76 2010 17 23
43. J. Kang Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS) Eur. J. Pharm. Biopharm. 80 2012 289 297
44. Q. Ma Uniform nano-sized valsartan for dissolution and bioavailability enhancement: influence of particle size and crystalline state Int. J. Pharm. 441 2013 75 81
45. H. Miura Terada, enhancement of dissolution rate and oral absorption of a poorly water-soluble drug, K-832, by adsorption onto porous silica using supercritical carbon dioxide Eur. J. Pharm. Biopharm. 76 2010 215 221
46. L. Sang General description of the adsorption of proteins at their iso-electric point in nanoporous materials Langmuir 27 2011 13828 13837
47. S. Šehić Investigation of intrinsic dissolution behavior of different carbamazepine samples Int. J. Pharm. 386 2010 77 90